scholarly journals DAS181 for Treatment of Parainfluenza Virus Infections in Hematopoietic Stem Cell Transplant Recipients at a Single Center

2016 ◽  
Vol 22 (5) ◽  
pp. 965-970 ◽  
Author(s):  
Mirella Salvatore ◽  
Michael J. Satlin ◽  
Samantha E. Jacobs ◽  
Stephen G. Jenkins ◽  
Audrey N. Schuetz ◽  
...  
Keyword(s):  
Stem Cell ◽  
Hematopoietic Stem Cell ◽  
Hematopoietic Stem Cell Transplant ◽  
Stem Cell Transplant ◽  
Parainfluenza Virus ◽  
Cell Transplant ◽  
Transplant Recipients ◽  
Virus Infections ◽  
Single Center ◽  
Hematopoietic Stem

scholarly journals Zika and chikungunya virus infections in hematopoietic stem cell transplant recipients and oncohematological patients

2017 ◽  
Vol 1 (10) ◽  
pp. 624-627 ◽  
Author(s):  
Clarisse Martins Machado ◽  
Bárbara Brito de Souza Pereira ◽  
Alvina Clara Felix ◽  
Maria Carolina Oliveira ◽  
Luiz Guilherme Darrigo ◽  
...  
Keyword(s):  
Stem Cell ◽  
Hematopoietic Stem Cell ◽  
Chikungunya Virus ◽  
Hematopoietic Stem Cell Transplant ◽  
Stem Cell Transplant ◽  
Cell Transplant ◽  
Transplant Recipients ◽  
Virus Infections ◽  
Hematopoietic Stem ◽  
Key Points

Key Points This article describes the first reports of Zika and chikungunya infections in HSCT recipients and oncohematological patients. Fever and exanthema should prompt arbovirus diagnosis, especially in areas at risk or in patients returning from endemic or epidemic regions.

scholarly journals DAS181 Treatment of Severe Parainfluenza Virus 3 Pneumonia in Allogeneic Hematopoietic Stem Cell Transplant Recipients Requiring Mechanical Ventilation

2016 ◽  
Vol 2016 ◽  
pp. 1-4 ◽  
Author(s):  
B. Dhakal ◽  
A. D’Souza ◽  
M. Pasquini ◽  
W. Saber ◽  
T. S. Fenske ◽  
...  
Keyword(s):  
Stem Cell ◽  
Hematopoietic Stem Cell ◽  
Hematopoietic Stem Cell Transplant ◽  
Stem Cell Transplant ◽  
Parainfluenza Virus ◽  
Cell Transplant ◽  
Transplant Recipients ◽  
Hematopoietic Stem ◽  
Life Threatening ◽  
Type 3

Parainfluenza virus (PIV) may cause life-threatening pneumonia in allogeneic hematopoietic stem cell transplant (HSCT) recipients. Currently, there are no proven effective therapies. We report the use of inhaled DAS181, a novel sialidase fusion protein, for treatment of PIV type 3 pneumonia in two allogeneic hematopoietic SCT recipients with respiratory failure.

Sign in / Sign up

Export Citation Format

Share Document